Janux Therapeutics, Inc. (JANX) Social Stream
JANUX THERAPEUTICS INC (JANX) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering JANUX THERAPEUTICS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-19 | 3 | $35 | $35 | $35 | $10.31 | 239.48% |
| 2022-09-17 | 2 | $35 | $29 | $32 | $10.31 | 210.38% |
| 2023-03-13 | 3 | $35 | $29 | $32 | $10.31 | 210.38% |
| 2023-03-17 | 4 | $35 | $26 | $30.5 | $10.31 | 195.83% |
| 2023-06-06 | 4 | $35 | $24 | $28.333 | $10.31 | 174.81% |
| 2023-11-08 | 4 | $35 | $24 | $28 | $10.31 | 171.58% |
| 2023-11-13 | 5 | $35 | $21 | $26.666 | $10.31 | 158.64% |
The Trend in the Analyst Price Target
Over the past 17 months, JANX's average price target has gone down $5.33.
Over the past 41 weeks, JANX's average upside potential has been 147.13%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-08 | 3 | 35 | 29 | 32.000 | 19.74 | 62.11% |
| 2023-03-13 | 3 | 35 | 29 | 32.000 | 13.76 | 132.56% |
| 2023-04-06 | 4 | 35 | 24 | 28.333 | 13.42 | 111.13% |
| 2023-05-10 | 4 | 35 | 24 | 28.333 | 13.86 | 104.42% |
| 2023-08-11 | 4 | 35 | 24 | 28.000 | 12.58 | 122.58% |
JANX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 4 | 0 | 0 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
Over the past 43 weeks, JANX's average broker recommendation rating improved by 0.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In the context of all US stocks, JANUX THERAPEUTICS INC's number of analysts covering the stock is greater than 106.09% of them.
- To contextualize these metrics, consider that out of all US stocks, JANUX THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 867.04% of them.
- JANUX THERAPEUTICS INC's variance in analysts' estimates is lower than -91.52% of Pharmaceutical Products stocks.
- To contextualize these metrics, consider that out of stocks in the small market cap category, JANUX THERAPEUTICS INC's average analyst price target is greater than 728.49% of them.
Stocks similar to JANUX THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are IMRX, RANI, and CYBN.
View All Top Stocks by Price Target
Make investment decisions regarding JANX using the data that counts. Try POWR Ratings for free.